home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
Cancer - Principles & Practice of Oncology
/
Oncology.iso
/
PPO
/
CHAP35
/
F5_7A.CAP
< prev
next >
Wrap
Text File
|
1999-06-07
|
301b
|
6 lines
FIGURE 35.5-7A. Disease-free survival of patients with suboptimal
stage III and IV ovarian cancer randomized to treatment with cisplatin
plus cyclophosphamide (solid line) or cisplatin plus paclitaxel
(dotted line). (McGuire WP, Hoskins WJ, Brody MF, et al. N Engl J Med
1996;334:1)